Morgan Stanley’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75K | Sell |
2,003
-62,234
| -97% | -$116K | ﹤0.01% | 7106 |
|
|
2025
Q1 | $114K | Buy |
64,237
+51,476
| +403% | +$91.6K | ﹤0.01% | 5952 |
|
|
2024
Q4 | $40.3K | Buy |
12,761
+10,350
| +429% | +$32.7K | ﹤0.01% | 6356 |
|
|
2024
Q3 | $4.97K | Sell |
2,411
-62,493
| -96% | -$129K | ﹤0.01% | 6921 |
|
|
2024
Q2 | $94.8K | Sell |
64,904
-399,562
| -86% | -$583K | ﹤0.01% | 5983 |
|
|
2024
Q1 | $1.09M | Sell |
464,466
-556,876
| -55% | -$1.3M | ﹤0.01% | 4910 |
|
|
2023
Q4 | $2.06M | Buy |
1,021,342
+802,199
| +366% | +$1.62M | ﹤0.01% | 4905 |
|
|
2023
Q3 | $1.06M | Buy |
219,143
+121,434
| +124% | +$588K | ﹤0.01% | 4767 |
|
|
2023
Q2 | $668K | Buy |
97,709
+79,850
| +447% | +$546K | ﹤0.01% | 5066 |
|
|
2023
Q1 | $129K | Buy |
17,859
+15,165
| +563% | +$110K | ﹤0.01% | 5907 |
|
|
2022
Q4 | $34.6K | Sell |
2,694
-6,313
| -70% | -$81K | ﹤0.01% | 6449 |
|
|
2022
Q3 | $127K | Sell |
9,007
-14,218
| -61% | -$200K | ﹤0.01% | 5959 |
|
|
2022
Q2 | $286K | Sell |
23,225
-12,593
| -35% | -$155K | ﹤0.01% | 5711 |
|
|
2022
Q1 | $608K | Buy |
35,818
+33,127
| +1,231% | +$562K | ﹤0.01% | 5292 |
|
|
2021
Q4 | $65K | Buy |
2,691
+2,600
| +2,857% | +$62.8K | ﹤0.01% | 6680 |
|
|
2021
Q3 | $3K | Buy |
+91
| New | +$3K | ﹤0.01% | 7614 |
|
|
2021
Q1 | – | Sell |
-1,671
| Closed | -$25K | – | 7586 |
|
|
2020
Q4 | $25K | Buy |
+1,671
| New | +$25K | ﹤0.01% | 6369 |
|
|
2019
Q2 | – | Sell |
-65
| Closed | -$1K | – | 6774 |
|
|
2019
Q1 | $1K | Buy |
65
+30
| +86% | +$462 | ﹤0.01% | 6547 |
|
|
2018
Q4 | $1K | Sell |
35
-176
| -83% | -$5.03K | ﹤0.01% | 6533 |
|
|
2018
Q3 | $10K | Buy |
+211
| New | +$10K | ﹤0.01% | 6308 |
|